CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Alpha (13335)
(-)
Architecture: Orthogonal Bundle (10391)
(-)
Topology: HMGR, N-terminal domain (22)
(-)
Homologous Superfamily: HMGR, N-terminal domain (22)
(-)
Human (Homo sapiens) (22)
1DQ8C:464-536; A:462-536; B:462-536; D:462-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG AND COA
1DQ9A:462-536; B:462-536; C:462-536; D:462-536COMPLEX OF CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG-COA
1DQAC:468-536; B:462-536; D:477-536; A:462-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG, COA, AND NADP+
1HW8B:462-536; A:462-536; C:488-536; D:488-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH COMPACTIN (ALSO KNOWN AS MEVASTATIN)
1HW9B:463-536; A:462-536; C:463-536; D:464-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH SIMVASTATIN
1HWIB:462-536; A:462-536; D:487-536; C:489-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATIN
1HWJB:463-536; D:462-536; A:462-536; C:462-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH CERIVASTATIN
1HWKB:463-536; A:462-536; C:462-536; D:463-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN
1HWLB:463-536; C:463-536; A:462-536; D:479-536COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ROSUVASTATIN (FORMALLY KNOWN AS ZD4522)
2Q1LC:462-536; A:459-536; D:462-536; B:459-536DESIGN AND SYNTHESIS OF PYRROLE-BASED, HEPATOSELECTIVE HMG-COA REDUCTASE INHIBITORS
2Q6BA:462-536; B:462-536; C:462-536; D:462-536DESIGN AND SYNTHESIS OF NOVEL, CONFORMATIONALLY RESTRICTED HMG-COA REDUCTASE INHIBITORS
2Q6CA:462-536; B:462-536; C:462-536; D:462-536DESIGN AND SYNTHESIS OF NOVEL, CONFORMATIONALLY RESTRICTED HMG-COA REDUCTASE INHIBITORS
2R4FD:458-536; A:462-536; B:462-536; C:462-536SUBSTITUTED PYRAZOLES AS HEPATSELECTIVE HMG-COA REDUCTASE INHIBITORS
3BGLA:462-536; B:462-536; C:462-536; D:459-536HEPATOSELECTIVITY OF STATINS: DESIGN AND SYNTHESIS OF 4-SULFAMOYL PYRROLES AS HMG-COA REDUCTASE INHIBITORS
3CCTA:462-536; B:462-536; C:462-536; D:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CCWA:462-536; B:462-536; C:462-536; D:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CCZD:458-536; A:462-536; B:462-536; C:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CD0D:458-536; A:462-536; B:462-536; C:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CD5A:462-536; B:462-536; C:462-536; D:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CD7C:462-536; A:459-536; D:462-536; B:459-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CDAD:462-536; A:462-536; B:462-536; C:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS
3CDBD:458-536; A:462-536; B:462-536; C:462-536THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS